NCT00040885: Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) |
|
|
| Completed | 3 | 67 | US | infliximab, docetaxel, placebo | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Anorexia, Cachexia, Fatigue, Lung Cancer | 02/06 | 10/08 | | |